Sale!

COL1A2 Gene Ehlers-Danlos Syndrome Type 7B Genetic Test

Original price was: $700.Current price is: $500.

-29%

The COL1A2 Gene Ehlers-Danlos Syndrome Type 7B NGS Genetic DNA Test is a comprehensive diagnostic tool that utilizes next-generation sequencing technology to identify mutations in the COL1A2 gene responsible for Ehlers-Danlos syndrome type 7B. This specialized test helps diagnose individuals with symptoms of hypermobile joints, skin hyperextensibility, and tissue fragility. By analyzing the complete coding region of the COL1A2 gene, the test provides crucial information for accurate diagnosis, family planning decisions, and personalized treatment approaches. The test is priced at $500 USD and offers valuable insights for patients and healthcare providers managing connective tissue disorders.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

COL1A2 Gene Ehlers-Danlos Syndrome Type 7B NGS Genetic DNA Test

Comprehensive Genetic Analysis for Connective Tissue Disorders

The COL1A2 Gene Ehlers-Danlos Syndrome Type 7B NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying mutations associated with arthrochalasia Ehlers-Danlos syndrome. This specialized genetic test utilizes advanced next-generation sequencing technology to provide comprehensive analysis of the COL1A2 gene, which plays a critical role in collagen formation and connective tissue integrity.

What This Test Measures and Detects

This sophisticated genetic test specifically targets the COL1A2 gene, which encodes the alpha-2 chain of type I collagen. Through comprehensive NGS analysis, the test identifies:

  • Pathogenic variants and mutations in the COL1A2 gene
  • Single nucleotide variants (SNVs) affecting collagen structure
  • Small insertions and deletions impacting protein function
  • Genetic alterations responsible for Ehlers-Danlos syndrome type 7B
  • Inheritance patterns for family risk assessment

Who Should Consider This Genetic Test

This test is particularly recommended for individuals presenting with:

  • Congenital hip dislocation or severe joint hypermobility
  • Recurrent joint subluxations or dislocations
  • Skin hyperextensibility with abnormal scarring
  • Muscle hypotonia in infancy
  • Family history of connective tissue disorders
  • Unexplained tissue fragility or easy bruising
  • Delayed motor development in childhood
  • Suspected collagen synthesis abnormalities

Clinical Benefits of Genetic Testing

Undergoing the COL1A2 genetic test provides numerous advantages for patients and healthcare providers:

  • Accurate Diagnosis: Confirms or rules out Ehlers-Danlos syndrome type 7B with precision
  • Personalized Treatment: Enables targeted management strategies based on genetic findings
  • Family Planning: Provides crucial information for reproductive decision-making
  • Early Intervention: Facilitates proactive management of potential complications
  • Genetic Counseling: Supports informed discussions about inheritance risks
  • Comprehensive Care: Guides multidisciplinary approach involving dermatologists, geneticists, and orthopedic specialists

Understanding Your Test Results

Your genetic test results will be carefully interpreted by our expert genetic counselors and clinical geneticists:

  • Positive Result: Indicates the presence of a pathogenic variant in the COL1A2 gene, confirming the diagnosis of Ehlers-Danlos syndrome type 7B
  • Negative Result: Suggests no disease-causing mutations were detected in the analyzed regions
  • Variant of Uncertain Significance: May identify genetic changes whose clinical significance requires further investigation
  • Carrier Status: Provides information about inheritance patterns for family members

All results include detailed explanations and recommendations for next steps in management and follow-up care.

Test Pricing and Details

Test Feature Details
Test Name COL1A2 Gene Ehlers-Danlos Syndrome Type 7B NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology

Pre-Test Requirements

Before undergoing testing, patients should provide:

  • Complete clinical history relevant to connective tissue symptoms
  • Participation in genetic counseling session
  • Detailed pedigree chart of family members affected by similar conditions
  • Documentation of previous diagnostic evaluations

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified collection centers ensures easy access to quality genetic testing services.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about your connective tissue health continue. Our comprehensive COL1A2 genetic testing provides the answers you need for informed healthcare decisions. Contact our genetic specialists today to schedule your test and begin your journey toward accurate diagnosis and personalized care.

Call or WhatsApp us now at +1(267) 388-9828 to book your COL1A2 Gene Ehlers-Danlos Syndrome Type 7B NGS Genetic DNA Test and take control of your genetic health today!